Suppr超能文献

肌萎缩侧索硬化症(ALS)基因中罕见变异的负担影响家族性和散发性ALS的生存率。

Burden of rare variants in ALS genes influences survival in familial and sporadic ALS.

作者信息

Pang Shirley Yin-Yu, Hsu Jacob Shujui, Teo Kay-Cheong, Li Yan, Kung Michelle H W, Cheah Kathryn S E, Chan Danny, Cheung Kenneth M C, Li Miaoxin, Sham Pak-Chung, Ho Shu-Leong

机构信息

Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong, P.R. China.

Department of Psychiatry, University of Hong Kong, Hong Kong, P.R. China; Centre for Genomic Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, P.R. China.

出版信息

Neurobiol Aging. 2017 Oct;58:238.e9-238.e15. doi: 10.1016/j.neurobiolaging.2017.06.007. Epub 2017 Jun 20.

Abstract

Genetic variants are implicated in the development of amyotrophic lateral sclerosis (ALS), but it is unclear whether the burden of rare variants in ALS genes has an effect on survival. We performed whole genome sequencing on 8 familial ALS (FALS) patients with superoxide dismutase 1 (SOD1) mutation and whole exome sequencing on 46 sporadic ALS (SALS) patients living in Hong Kong and found that 67% had at least 1 rare variant in the exons of 40 ALS genes; 22% had 2 or more. Patients with 2 or more rare variants had lower probability of survival than patients with 0 or 1 variant (p = 0.001). After adjusting for other factors, each additional rare variant increased the risk of respiratory failure or death by 60% (p = 0.0098). The presence of the rare variant was associated with the risk of ALS (Odds ratio 1.91, 95% confidence interval 1.03-3.61, p = 0.03), and ALS patients had higher rare variant burden than controls (MB, p = 0.004). Our findings support an oligogenic basis with the burden of rare variants affecting the development and survival of ALS.

摘要

基因变异与肌萎缩侧索硬化症(ALS)的发病有关,但尚不清楚ALS相关基因中罕见变异的负荷是否会影响患者的生存期。我们对8例携带超氧化物歧化酶1(SOD1)突变的家族性ALS(FALS)患者进行了全基因组测序,并对46例居住在香港的散发性ALS(SALS)患者进行了全外显子组测序,发现67%的患者在40个ALS相关基因外显子中至少有1个罕见变异;22%的患者有2个或更多罕见变异。有2个或更多罕见变异的患者比有0个或1个变异的患者存活概率更低(p = 0.001)。在对其他因素进行校正后,每增加一个罕见变异,呼吸衰竭或死亡风险增加60%(p = 0.0098)。罕见变异的存在与患ALS的风险相关(优势比1.91,95%置信区间1.03 - 3.61,p = 0.03),且ALS患者的罕见变异负荷高于对照组(MB,p = 0.004)。我们的研究结果支持寡基因发病机制,即罕见变异负荷影响ALS的发生发展及患者生存期。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验